Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 064370/0389 | |
| Pages: | 9 |
| | Recorded: | 07/25/2023 | | |
| Attorney Dkt #: | 01275-0036-04US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18069511
|
Filing Dt:
|
12/21/2022
|
|
Publication #:
|
|
Pub Dt:
|
07/06/2023
| | | | |
|
Title:
|
Anti-CSF1R Antibody and Anti-PD-1 Antibody Combination Therapy for Cancer
|
|
|
Assignee
|
|
|
|
|
| ONE AMGEN CENTER DRIVE |
| THOUSAND OAKS, CALIFORNIA 91320-1799 |
|
|
Correspondence name and address
|
| |
MCNEILL BAUR PLLC
|
| |
125 CAMBRIDGE PARK DRIVE
|
| |
SUITE 301
|
| |
CAMBRIDGE, MA 02140
|
Search Results as of:
05/31/2024 03:24 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
